Atlas Trials

L-TIL in Patients With Malignancy Resistance to Anti-PD-1 Therapy

Clinical trial NCT04268108 · UNKNOWN

Trial details

NCT number
NCT04268108
Sponsor
Henan Cancer Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Advanced Solid Tumor
Start date
2020-04-02
Primary completion
2022-02-19
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.